Cytomegaloviruses (CMV), the prototypical β-herpesviruses, have co-evolved with their hosts and thus acquired multiple strategies for modulation of the immune response. Viral engagement of pattern recognition receptors (PRR), such as toll-like receptors (TLRs) and cytosolic nucleic acids sensors, initiates the host immune response through activation of elaborate signalling programs. The ensuing inflammatory response is further sustained and amplified through cytokines, such as IL-1β, activating signalling pathways greatly overlapping those utilized by TLRs. The central hypothesis of this thesis is that a viral counter-measure by murine CMV (MCMV) involves specific targeting of TLR- and IL-1β-induced signalling along the MyD88 to NF-κB pathway. To test this hypothesis MCMV inhibition of IL-1β signalling was initially investigated in a fibroblast cell line. It was demonstrated that in MCMV infected cells IL-1β-induced IκBα degradation is largely inhibited. Comparison of productive and non-productive infection showed this modulation requires de-novo viral gene expression beyond the immediate early region. Further investigations utilising a ORF M45 deletion mutant identified viral gene M45 as necessary for mediating the observed modulation of IL-1β- induced IκBα degradation. To further test the hypothesis, studies were extended to include TLR stimulation in the context of bone marrow-derived macrophages (BMDM) infection. It was found that TLR7/9-induced NF-κB activation is inhibited in MCMV infected BMDM. Overall, data presented in this study demonstrate a previously unrecognised MCMV inhibition of IL-1β- and TLR7/9-induced NF-κB activation, and indicate a role for viral gene M45 in mediating this effect.

Os tecidos pulpar e periodontal são frequentemente agredidos por fatores ambientais como calor, trauma mecânico e micro-organismos, sendo estes considerados o fator etiológico principal das periodontopatias e periapicopatias. Dentre as células residentes desses tecidos, especial atenção tem sido dada ao papel dos fibroblastos no desenvolvimento da resposta imune. Fibroblastos são células que respondem à estímulos microbianos e existem evidências do papel de receptores do tipo Toll (TLR) no reconhecimento desses estímulos. Dessa forma, o presente trabalho teve como objetivo principal avaliar o reconhecimento de Candida albicans por fibroblastos gengivais e pulpares. Para tal, fibroblastos isolados a partir de tecido gengival e pulpar de camundongos do grupo controle e deficientes de TLR2, CD14 e MyD88 foram avaliados quanto à expressão de TLRs e moléculas de superfície, resposta proliferativa e produção de citocinas (TGF-β, IL-1β, TNF-α, IL-13 e IL-6), após a estimulação com agonistas de TLR2, TLR4 e C. albicans. Fibroblastos gengivais e pulpares, apesar de provenientes de tecidos diferentes, apresentaram características morfológicas semelhantes. Contudo, a cinética de crescimento dos fibroblastos gengivais deficientes de MyD88 foi mais lenta, e fibroblastos pulpares demoraram mais tempo para surgir a partir dos fragmentos de tecido. A ausência de TLR2 e da molécula adaptadora MyD88 não afetaram a produção de colágeno Tipo I pelos fibroblastos gengivais. Entretanto, fibroblastos deficientes de CD14 apresentaram baixa produção de colágeno. Ademais, os fibroblastos gengivais expressaram TLR2, TLR3, TLR4, assim como as moléculas de adesão ICAM-1 e CD44. A ausência de TLR2 e CD14 interferiu na resposta proliferativa de fibroblastos gengivais e pulpares, respectivamente. O reconhecimento de C. albicans por fibroblastos gengivais e pulpares modulou a produção das citocinas. A produção de TNF-α foi dependente da sinalização via MyD88, CD14 e TLR2, enquanto que a produção de IL-1β e IL-13 foi dependente de TLR2. / Pulpal and periapical tissue are frequently injured by heat, mechanical trauma and microorganisms, which are considered the main etiological factor of periodontal and endodontic diseases. Among these tissue resident cells, special attention has been given to fibroblasts in the immune response. Fibroblasts are cells that recognize pathogens through Toll like receptors (TLR). The aim of this study was to evaluate the recognition of Candida albicans by pulpal and gingival fibroblasts from TLR2, CD14, MyD88 knockout mice and control group mice. The results were analyzed concerning the expression of TLR(s) and surface molecules, proliferative response and citokynes production (TGF-β, IL-1β, TNF-α, IL-13 e IL-6) after the cells stimulation with TLR2, TLR4 and C.albicans agonists. Gingival and Pulpal fibroblasts, even isolated from different tissue, showed morphological similarities; however, gingival fibroblast deficient of MyD88 show lower proliferative response and pulpa l fibroblasts needed more time to detach from tissue fragments. The production of Type I collagen was affected in gingival cells deficient of CD14. Gingival fibroblasts expressed TLR2, TLR3, TLR4, and the adhesion molecules (ICAM-1 and CD44). The absence of TLR2 and CD14 interfered with the proliferative response of pulpal and gingival fibroblasts, respectively. The recognition of C. albicans by gingival and pulpal fibroblasts modulated the citokynes production. TNF-α production after the recognition of C. albicans was dependent from MyD88, CD14 and TLR2 molecules, whereas the production of IL-1β and IL-13 was dependent of TLR2.

Os tecidos pulpar e periodontal são frequentemente agredidos por fatores ambientais como calor, trauma mecânico e micro-organismos, sendo estes considerados o fator etiológico principal das periodontopatias e periapicopatias. Dentre as células residentes desses tecidos, especial atenção tem sido dada ao papel dos fibroblastos no desenvolvimento da resposta imune. Fibroblastos são células que respondem à estímulos microbianos e existem evidências do papel de receptores do tipo Toll (TLR) no reconhecimento desses estímulos. Dessa forma, o presente trabalho teve como objetivo principal avaliar o reconhecimento de Candida albicans por fibroblastos gengivais e pulpares. Para tal, fibroblastos isolados a partir de tecido gengival e pulpar de camundongos do grupo controle e deficientes de TLR2, CD14 e MyD88 foram avaliados quanto à expressão de TLRs e moléculas de superfície, resposta proliferativa e produção de citocinas (TGF-β, IL-1β, TNF-α, IL-13 e IL-6), após a estimulação com agonistas de TLR2, TLR4 e C. albicans. Fibroblastos gengivais e pulpares, apesar de provenientes de tecidos diferentes, apresentaram características morfológicas semelhantes. Contudo, a cinética de crescimento dos fibroblastos gengivais deficientes de MyD88 foi mais lenta, e fibroblastos pulpares demoraram mais tempo para surgir a partir dos fragmentos de tecido. A ausência de TLR2 e da molécula adaptadora MyD88 não afetaram a produção de colágeno Tipo I pelos fibroblastos gengivais. Entretanto, fibroblastos deficientes de CD14 apresentaram baixa produção de colágeno. Ademais, os fibroblastos gengivais expressaram TLR2, TLR3, TLR4, assim como as moléculas de adesão ICAM-1 e CD44. A ausência de TLR2 e CD14 interferiu na resposta proliferativa de fibroblastos gengivais e pulpares, respectivamente. O reconhecimento de C. albicans por fibroblastos gengivais e pulpares modulou a produção das citocinas. A produção de TNF-α foi dependente da sinalização via MyD88, CD14 e TLR2, enquanto que a produção de IL-1β e IL-13 foi dependente de TLR2. / Pulpal and periapical tissue are frequently injured by heat, mechanical trauma and microorganisms, which are considered the main etiological factor of periodontal and endodontic diseases. Among these tissue resident cells, special attention has been given to fibroblasts in the immune response. Fibroblasts are cells that recognize pathogens through Toll like receptors (TLR). The aim of this study was to evaluate the recognition of Candida albicans by pulpal and gingival fibroblasts from TLR2, CD14, MyD88 knockout mice and control group mice. The results were analyzed concerning the expression of TLR(s) and surface molecules, proliferative response and citokynes production (TGF-β, IL-1β, TNF-α, IL-13 e IL-6) after the cells stimulation with TLR2, TLR4 and C.albicans agonists. Gingival and Pulpal fibroblasts, even isolated from different tissue, showed morphological similarities; however, gingival fibroblast deficient of MyD88 show lower proliferative response and pulpa l fibroblasts needed more time to detach from tissue fragments. The production of Type I collagen was affected in gingival cells deficient of CD14. Gingival fibroblasts expressed TLR2, TLR3, TLR4, and the adhesion molecules (ICAM-1 and CD44). The absence of TLR2 and CD14 interfered with the proliferative response of pulpal and gingival fibroblasts, respectively. The recognition of C. albicans by gingival and pulpal fibroblasts modulated the citokynes production. TNF-α production after the recognition of C. albicans was dependent from MyD88, CD14 and TLR2 molecules, whereas the production of IL-1β and IL-13 was dependent of TLR2.

Obesity over the last several has become a major health concern in our country as well as the world. Obesity is also one of the risk factors which lead to several inflammatory complications such as diabetes, artherosclerosis, etc. Two leading factors involved in the causes of inflammatory complications include leptin and low dose endotoxin lipopolysaccharide (LPS). However, the mechanism underlying the involvement of these two mediators is not clearly understood. The purpose of this study is to understand the mechanism underlying inflammatory complications caused by leptin and low dose endotoxin most recently coined metabolic endotoxemia. Interleukin-Receptor Associated Kinase 1 (IRAK-1) is an intracellular signaling component shown to activate NFκB which leads to the induction of proinflammatory mediators. Deletion of IRAK-1 in mice has beneficial effects in alleviating inflammatory complications and human variations in IRAK-1 gene are correlated with higher risks for inflammatory diseases. Therefore, we hypothesized that IRAK-1 is critically involved for the induction of proinflammatory mediators induced by leptin and low dose LPS. IL-6 mRNA levels were measured in THP-1 (human monocytic cells) and wild type and IRAK-deficient bone marrow derived macrophages (BMDM) challenged with different combinations of leptin and LPS. Data shows that leptin alone will not induce inflammatory mediators. However, increased induction of IL-6 was observed in a synergistic manner involving both LPS and leptin in an IRAK-1 dependent manner causing a robust inflammatory response. With regard to the effect of low dose LPS, we observed that human monocytic cells treated with low concentrations of LPS showed a mild yet sustained induction of proinflammatory cytokines, which is contrast to the robust and transient induction of cytokines by a high dose LPS. To further determine the molecular mechanisms, we measured several key signaling molecules that include IRAK-1, IKKepsilon, and C/EBPdelta. Our study revealed a novel mechanism that appears to be distinct from the traditional NFï «B pathway responsible for the effect of low dose LPS. / Ph. D.

Ce travail de thèse s’est attaché à comprendre le lien étroit entre les dérégulations métaboliques et les dérégulations du système immunitaire, dans le cadre du modèle de diabète auto-immun de la souris NOD. Nous avons constaté que les bezafibrates protègent les souris NOD du diabète. Nous avons mis en évidence que ceci était lié à une diminution de l’infiltration des ilots beta du pancréas par les lymphocytes et cellules présentatrice d’antigen (CPA). La diminution d’IL-6 dans le sérum des souris traitées suggère une diminution générale de l’inflammation. Aussi, nous avons évalué l’implication du traitement en dehors du système immunitaire, en l’occurrence sur le stress cellulaire et la survie des cellules beta des ilots de Langherans, en utilisant une méthode de streptozotocine à faible dose, et nous avons observé une protection des souris traitées par les bezafibrates. Dans une deuxième partie de l’étude, nous avons observé qu’il existait au niveau du système immunitaire inné une surexpression des Toll-like récepteurs (TLR) 1, 2 et 6 dans les souris NOD comparées aux souris contrôles C57BL/6, ceci au niveau transcriptionnel ainsi qu’au niveau traductionnel. Nous avons ensuite démontré que cette surexpression avait une légitimité fonctionnelle. En effet, les CPA sécrètent plus d’Interleukine 6 (IL-6), et les cellules B, plus d’Immunoglobuline M (IgM). Nous avons poursuivi notre étude en modulant le contenu sérique en lipides dans nos souris NOD, en utilisant un régime gras pour augmenter la lipidémie et des bezafibrates hypolipidémiantes. Nous n’avons pas observé de modulation majeure de l’expression de TLR2 et TLR6, mais il est à noter que les CPA issues des souris soumises au régime gras sont plus susceptible à la réponse au ligand synthétique FSL-1 de TLR 2/6, qui sécrètent alors plus d’IL-6 que les NOD contrôles ou traitées aux bezafibrates. Nous avons pu ainsi souligner l’importance des liens entre le métabolisme et le système immunitaire, dans l’apparition de la maladie auto-immune que constitue le diabète de type 1. / In this thesis we sought to understand the link between metabolic deregulation and immune deregulation in the context of the NOD mouse autoimmune model. We observed that bezafibrates protect NOD mice from type 1 diabetes (T1D). We showed that pancreas beta islet infiltration by lymphocytes and APCs was diminished. IL-6 decrease in bezafibrate treated mice serum suggested a general dampening down of inflammation. Besides we evaluated the effect of bezafibrate out of the immune system by using a low-dose streptozotocin method and we observed that bezafibrate mice treated were protected. In a second part of this study we observed an overexpression of Toll-like receptors (TLR) 1, 2, 6 in NOD mice compared to C57BL/6 controls. This was noticeable at the transcription and translation level. We showed that this overexpression had a functional role. Indeed APCs from NODs secreted more IL-6, and B cells secreted more IgM when stimulated with corresponding ligands. We then modified the lipid content of NOD mice by using bezafibrates to decrease lipidemia, and a high fat diet (HFD) to increase lipidemia. No modulation of TLR2 and TLR6 expression was observed. However, APCs from HFD mice were more susceptible to TLR2/6 ligand FSL-1 stimulation by secreting more IL-6 than control or bezafibrate treated NODs. We here highlight the important links existing between metabolism immunity in the autoimmune T1D onset

Hepatitis B virus (HBV) infection is one of the major causes of chronic and cancerous liver disease. Elimination of HBV from chronically infected patients by recombinant interferon α (IFNα) monotherapy shows that the mechanisms of the innate immunity play an important role in suppressing viral infection. However, the mechanisms of recognition of the HBV genome and its escape from the mechanisms of natural immunity are still little known. One of the principal factors enabling the virus to escape from cellular restriction mechanisms is the HBx viral protein. HBx is a 154 amino acid pleiotropic multifunctional protein affecting transcription, signal transduction, cell cycle, protein degradation, apoptosis, and chromosomal stability in the host cell. Previous results from our laboratory have shown that activation of the MEK1/2-ERK signaling pathway in plasmacytoid dendritic cells leads to inhibition of IFNα production. The aim of my work was to determine whether HBx activates the MEK1/2-ERK pathway and thus inhibits IFN type I production also in hepatocytes. For this purpose, I monitored HBx production in the Huh7 hepatoma cell line by transfecting the bicistronic plasmid pHBx- IRES-EGFP and Western blotting. Using the same method, I monitored activation of the MEK1/2-ERK signaling pathway by ERK...

Le CD40 est une glycoprotéine transmembranaire de type I, appartenant à la famille des TNFRs, exprimée à la surface des cellules immunitaires, hématopoïétiques, vasculaires, épithéliales, et d’autres types de cellules, y compris les cellules tumorales. Le CD40 ne possédant pas de domaine kinase, pour induire un signal il interagit directement ou indirectement avec des protéines adaptatrices telles que les TRAFs et les JAKs. L’interaction du CD40 avec son principal ligand, le CD154, joue un rôle primordial dans la régulation de la réponse immunitaire et le maintien de l’homéostasie. L’activation du CD40 à la surface des cellules B augmente leur capacité de présentation d’antigène, en plus d’induire la prolifération, la commutation isotypique et l’apoptose. Les patients souffrant de mutations au niveau du gène codant pour le CD40 ou de son ligand sont immunosupprimés et sensibles à des infections opportunistes. Des études ont montré que le CD40 comme d’autres membres de la famille des TNFRs est capable de former des homodimères. Plus récemment, on a montré que la formation du CD40 homodimère est le résultat de son engagement sur les cellules B. En plus, cette homodimérisation du CD40 est importante pour la phosphorylation de l’Akt. L’interaction CD40/CD154 peut avoir un rôle direct dans l’immunothérapie par l’induction de l’apoptose de certaines cellules cancéreuses ou un rôle indirect en activant les cellules présentatrices d’antigènes (CPA) afin d'augmenter l’efficacité de l’activation des cellules T cytotoxiques. Nos résultats montrent que l’induction de la mort cellulaire par le CD40 requiert la perméabilisation du lysosome, la libération de la cathepsine B, la présence de ROS et une interaction avec le TRAF6, cette mort cellulaire programmée est plus importante en présence de la forme monomérique du CD40, muté au niveau de la cystéine 238. Par ailleurs, l’homodimérisation du CD40 requerrait sa translocation vers les radeaux lipidiques et nécessiterait la présence des ROS. Cette homodimérisation du CD40 semble être importante pour l’activation des cellules B par le biais de l’induction de l’expression du CD23, CD69 et CD80. De plus, nos résultats montrent pour la première fois une implication du CD40 homodimère dans l’induction du CD23 par le biais du TLR4. Nos résultats soulignent l’importance du CD40 homodimère dans certaines voies de signalisation. Ainsi, ils mettent en évidence le rôle de la Cys-238 dans la coopération entre des récepteurs de la réponse immunitaire innée et adaptative. Toutes ces données permettraient une meilleure compréhension de certaines voies de signalisation impliquées dans plusieurs maladies auto-immunes et faisant objet de plusieurs essais thérapeutiques. / CD40 is a type I transmembrane glycoprotein belonging to the TNFRs family, which is expressed on the surface of immune, hematopoietic cells, vascular, epithelial, and other cell types, including a wide range of tumour cells. CD40 does not have a kinase domain. Thus, to induce a signal, CD40 interacts directly or indirectly with adapter proteins such as TRAFs and Jaks. The interaction of CD40 with its main ligand, CD154, plays an important role in regulating the immune response and homeostasis. The activation of CD40 on the surface of B cells increases its ability to promote antigen presentation, in addition to inducing proliferation, isotype switching, and apoptosis. Patients affected by mutations in the gene encoding the CD40 or its ligand are immunosuppressed and susceptible to opportunistic infections. Studies have shown that CD40, as other members of the family of TNFRs is capable of forming homodimers. More recently, it was shown that the formation of the CD40 homodimer is the result of the engagement of CD40 on B cells by CD154. In addition, the homodimerization of CD40 is important for the phosphorylation of Akt. The CD40/CD154 interaction can have a direct role in immunotherapy by inducing apoptosis of some cancer cells or an indirect role in activating antigen-presenting cells (APCs), thereby increasing the effectiveness of activation of cytotoxic T cells. Our results show that the induction of cell death by CD40 requires permeabilization of the lysosome, the release of cathepsin B, the presence of ROS and interaction with TRAF6, this programmed cell death is greater in the presence of the monomeric form of CD40, due to a mutation at the level of the cysteine 238. Moreover, the homodimerization of CD40 requires its translocation to lipid rafts and the presence of ROS. This homodimerization is necessary for the CD40 B-cell activation via the induction of expression of CD23, CD69 and CD80. In addition, our results show for the first time the involvement of the CD40 homodimer in the induction of CD23 expression via TLR4. Our results emphasize the importance of CD40 homodimer in signaling pathways and highlight the role of Cys-238 in the cooperation between receptors of the innate and adaptive immune response. All together our results will allow a better understanding of CD40 signaling pathways involved in several autoimmune diseases, which give a rise to a better therapeutic trial design.

Le CD40 est une glycoprotéine transmembranaire de type I, appartenant à la famille des TNFRs, exprimée à la surface des cellules immunitaires, hématopoïétiques, vasculaires, épithéliales, et d’autres types de cellules, y compris les cellules tumorales. Le CD40 ne possédant pas de domaine kinase, pour induire un signal il interagit directement ou indirectement avec des protéines adaptatrices telles que les TRAFs et les JAKs. L’interaction du CD40 avec son principal ligand, le CD154, joue un rôle primordial dans la régulation de la réponse immunitaire et le maintien de l’homéostasie. L’activation du CD40 à la surface des cellules B augmente leur capacité de présentation d’antigène, en plus d’induire la prolifération, la commutation isotypique et l’apoptose. Les patients souffrant de mutations au niveau du gène codant pour le CD40 ou de son ligand sont immunosupprimés et sensibles à des infections opportunistes. Des études ont montré que le CD40 comme d’autres membres de la famille des TNFRs est capable de former des homodimères. Plus récemment, on a montré que la formation du CD40 homodimère est le résultat de son engagement sur les cellules B. En plus, cette homodimérisation du CD40 est importante pour la phosphorylation de l’Akt. L’interaction CD40/CD154 peut avoir un rôle direct dans l’immunothérapie par l’induction de l’apoptose de certaines cellules cancéreuses ou un rôle indirect en activant les cellules présentatrices d’antigènes (CPA) afin d'augmenter l’efficacité de l’activation des cellules T cytotoxiques. Nos résultats montrent que l’induction de la mort cellulaire par le CD40 requiert la perméabilisation du lysosome, la libération de la cathepsine B, la présence de ROS et une interaction avec le TRAF6, cette mort cellulaire programmée est plus importante en présence de la forme monomérique du CD40, muté au niveau de la cystéine 238. Par ailleurs, l’homodimérisation du CD40 requerrait sa translocation vers les radeaux lipidiques et nécessiterait la présence des ROS. Cette homodimérisation du CD40 semble être importante pour l’activation des cellules B par le biais de l’induction de l’expression du CD23, CD69 et CD80. De plus, nos résultats montrent pour la première fois une implication du CD40 homodimère dans l’induction du CD23 par le biais du TLR4. Nos résultats soulignent l’importance du CD40 homodimère dans certaines voies de signalisation. Ainsi, ils mettent en évidence le rôle de la Cys-238 dans la coopération entre des récepteurs de la réponse immunitaire innée et adaptative. Toutes ces données permettraient une meilleure compréhension de certaines voies de signalisation impliquées dans plusieurs maladies auto-immunes et faisant objet de plusieurs essais thérapeutiques. / CD40 is a type I transmembrane glycoprotein belonging to the TNFRs family, which is expressed on the surface of immune, hematopoietic cells, vascular, epithelial, and other cell types, including a wide range of tumour cells. CD40 does not have a kinase domain. Thus, to induce a signal, CD40 interacts directly or indirectly with adapter proteins such as TRAFs and Jaks. The interaction of CD40 with its main ligand, CD154, plays an important role in regulating the immune response and homeostasis. The activation of CD40 on the surface of B cells increases its ability to promote antigen presentation, in addition to inducing proliferation, isotype switching, and apoptosis. Patients affected by mutations in the gene encoding the CD40 or its ligand are immunosuppressed and susceptible to opportunistic infections. Studies have shown that CD40, as other members of the family of TNFRs is capable of forming homodimers. More recently, it was shown that the formation of the CD40 homodimer is the result of the engagement of CD40 on B cells by CD154. In addition, the homodimerization of CD40 is important for the phosphorylation of Akt. The CD40/CD154 interaction can have a direct role in immunotherapy by inducing apoptosis of some cancer cells or an indirect role in activating antigen-presenting cells (APCs), thereby increasing the effectiveness of activation of cytotoxic T cells. Our results show that the induction of cell death by CD40 requires permeabilization of the lysosome, the release of cathepsin B, the presence of ROS and interaction with TRAF6, this programmed cell death is greater in the presence of the monomeric form of CD40, due to a mutation at the level of the cysteine 238. Moreover, the homodimerization of CD40 requires its translocation to lipid rafts and the presence of ROS. This homodimerization is necessary for the CD40 B-cell activation via the induction of expression of CD23, CD69 and CD80. In addition, our results show for the first time the involvement of the CD40 homodimer in the induction of CD23 expression via TLR4. Our results emphasize the importance of CD40 homodimer in signaling pathways and highlight the role of Cys-238 in the cooperation between receptors of the innate and adaptive immune response. All together our results will allow a better understanding of CD40 signaling pathways involved in several autoimmune diseases, which give a rise to a better therapeutic trial design.

Plasmacytoid dendritic cells (pDC) represent innate immune cells capable to detect viruses in their endosomal environment via Toll-like receptors (TLRs). Viral nuclear acid recognition leads to the massive production of type I interferon (IFN I) and induction of the antiviral state in uninfected cells. Crosslinking of the surface regulatory receptors, such as BDCA-2, with monoclonal antibodies or with some viruses leads to the activation of MEK1/2- ERK signaling pathway and inhibition of IFN I production in pDC. In this study, the role of MEK1/2 kinase has been highlighted. Its inhibition reversed the inhibitory effect of BDCA-2 crosslinking and its direct activation with PMA led to the inhibition of IFN-α production. Yet an unclear role of pDC in sensing of BK polyomavirus virus (BKV) responsible for kidney transplant rejection was investigated as a major topic of this thesis. Experiments with the pDC cell line Gen2.2 and HRPTEC primary cell line showed that pDCs were not able to detect BKV particles, however, exposure of activated Gen2.2 cells to BKV inoculum dramatically upregulated production of IFN-α. Most importantly, coculture of Gen2.2 cells with BKV- infected HRPTEC cells resulted in IFN-α and TNF-α production, which was prevented by Bafilomycin. These results suggest that BKV-infected...

Plasmacytoid dendritic cells (pDC) are a highly specialized subset of immune cells that sense viral nucleic acids by endosomal toll-like receptors 7 and 9 (TLR7/9). Activation of TLR7/9 leads to the production of type I interferons (IFN-I). Moreover, pDC contribute to the antiviral response by presenting viral antigens to T lymphocytes and link innate and adaptive immunity. pDC need to be properly regulated in order to limit excessive production of IFN-I that is associated with autoimmune diseases. Therefore, pDC possess a battery of regulatory receptors (RR) that limit TLR7/9-mediated cytokine production. This thesis focuses on the mechanism of RR-mediated inhibition of IFN-I production in pDC and explores interactions between pDC and two enveloped viruses, that possess the ability to hijack RR in pDC: hepatitis B virus (HBV) and human immunodeficiency virus (HIV). We showed, that MEK-ERK signaling pathway plays an active role in RR-mediated inhibition of IFN-I in pDC. Our results indicate that in line with other studies of our group, pharmacological targeting of MEK1/2-ERK signaling could be a strategy to re-establish immunogenic activity of pDC. Then, we investigated whether antiretroviral therapy (ART) in a cohort of 21 treatment-naive chronic HIV-infected patients has restored the number and...